$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Mediators appointed in J&J bankruptcy talc case to determine amount of trust fund
08:58pm, Tuesday, 08'th Mar 2022 Seeking Alpha
A federal bankruptcy court judge has appointed two mediators who will work to determine the amount of money Johnson & Johnson (JNJ) will put in a trust fund to resolve ~38K talc cases.
News24.com | Aspen signs deal with J&J to launch Aspenovax Covid-19 vaccine
08:00pm, Tuesday, 08'th Mar 2022 News24
Aspen has signed a contract with Johnson & Johnson to manufacture and sell an Aspen-branded Covid-19 vaccine, Aspenovax, throughout Africa.
Johnson & Johnson inks deal with Aspen as COVID-19 vaccine makers focus on Africa
04:26pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Johnson & Johson (JNJ) became the latest COVID-19 vaccine maker to focus on the African continent. The U.S
S.Africa''s Aspen signs deal to package and sell J&J COVID vaccine
04:06pm, Tuesday, 08'th Mar 2022 Reuters
South African drugmaker Aspen Pharmacare on Tuesday concluded an agreement with Johnson & Johnson to package, sell and distribute the American group''s COVID-19 vaccines under its own brand in Africa.
Johnson & Johnson Announces Landmark Agreement to Enable its COVID-19 Vaccine to be Manufactured and Made Available by an African Company for People Living in Africa
03:50pm, Tuesday, 08'th Mar 2022 Zambian News Network
Aspen will manufacture and provide the Johnson & Johnson COVID-19 vaccine under its own brand name per the terms of agreement Ensuring equitable, global access to COVID-19 vaccines has been a pillar of Johnson & Johnson’s response since the earliest days of the pandemic The production of COVID-19 vaccines on multiple continents is critical to […]
JNJ Regrets Paying For Controversial Prison Testing With Asbestos: Bloomberg
01:47pm, Tuesday, 08'th Mar 2022 Benzinga
According to a Bloomberg News report , unsealed court documents show that Johnson & Johnson (NYSE: JNJ ) paid for a study that injected ten incarcerated Black men with asbestos as part of the Company''s early talcum powder trials. In one study, inmates were paid to be injected with potentially cancer-causing asbestos so JNJ could compare its effect on their skin versus that of talc, a key component in its baby powder. While news of the 50-year-old study itself isn''t new, … Full story available on Benzinga.com
Johnson & Johnson (JNJ) Management at 42nd Annual Cowen Health Care Conference (Transcript)
06:19pm, Monday, 07'th Mar 2022 Seeking AlphaJohnson & Johnson: Still A Bit Too Expensive
04:44pm, Monday, 07'th Mar 2022 Seeking AlphaJohnson & Johnson’s Janssen unit and Legend Biotech ink interim supply deal (NASDAQ:LEGN)
11:42am, Monday, 07'th Mar 2022 Seeking Alpha
The clinical-stage biopharmaceutical company, Legend Biotech (LEGN), announced on Monday an Interim Product Supply Agreement with Janssen Biotech of Johnson & Johnson (JNJ) for…
Johnson & Johnson is in talks for biotech deals in China - FT
12:16pm, Sunday, 06'th Mar 2022 Seeking Alpha
Johnson & Johnson (JNJ) is in negotiations with two Chinese biotech companies for partnerships, The Financial Times reported Sunday, citing a senior executive of the U.S. pharma giant
Benzinga Bulls And Bears Of The Past Week: Shopify, Palantir, Apple, Meta, Twitter, Johnson & Johnson, American Express And More
06:12pm, Saturday, 05'th Mar 2022 Benzinga
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week''s bullish calls included a top e-commerce platform and a software company behind a popular video teleconferencing app. A leading pharmaceutical company along with a microblogging/social networking service company were among the bearish calls seen. Strong jobs numbers and an unemployment rate of 3.8% reported on Friday were not enough to push major indexes higher. The Dow Jones Industrial Average ended its fourth week of losses and bond yields recorded their biggest one-week fall since March 2020 as the Russian military invasion of Ukraine intensified. The Dow finished the week down 1.3%, the S&P 500 also fell by 1.3% while the Nasdaq dropped by 2.8% for the week. The price of front-month futures for Brent Crude Oil rose 25% this week to $118.11, closing at its highest level since 2013. Goldman Sachs analysts said Thursday that higher oil prices and the resulting spike in gas prices are the “key inflation risk for the United States.” Benzinga continues to examine the prospects for many of the stocks most popular with investors.
Biologics Global Market Report 2022
10:04am, Friday, 04'th Mar 2022 GlobeNewswire
Major companies in the biologics market include AbbVie, Johnson & Johnson, Amgen, Sanofi S. A, F. Hoffmann-La Roche Ltd. , GlaxosmithKline, Novartis AG, Pfizer Inc. , Teva Pharmaceuticals and CSL. Major companies in the biologics market include AbbVie, Johnson & Johnson, Amgen, Sanofi S. A, F. Hoffmann-La Roche Ltd. , GlaxosmithKline, Novartis AG, Pfizer Inc. , Teva Pharmaceuticals and CSL.
Pharmaceutical Drugs Global Market Report 2022
09:59am, Friday, 04'th Mar 2022 GlobeNewswire
Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S. A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co. and CJ Corp. Major companies in the pharmaceutical drugs market include Bristol-Myers Squibb, Sanofi S. A, Johnson & Johnson, Novartis AG, Bayer AG, Abbott Laboratories, GlaxosmithKline, AstraZenec, Merck & Co. and CJ Corp.
Pharmaceuticals Global Market Report 2022
08:59am, Friday, 04'th Mar 2022 GlobeNewswire
Major companies in the pharmaceuticals market include Johnson & Johnson, Novartis AG, Bristol-Myers Squibb, AbbVie, Sanofi S. A, Pfizer Inc. , GlaxosmithKline, F. Hoffmann-La Roche Ltd. , Merck & Co. and AstraZeneca. Major companies in the pharmaceuticals market include Johnson & Johnson, Novartis AG, Bristol-Myers Squibb, AbbVie, Sanofi S. A, Pfizer Inc. , GlaxosmithKline, F. Hoffmann-La Roche Ltd. , Merck & Co. and AstraZeneca.
Anti-Infective Drugs Global Market Report 2022
08:24am, Friday, 04'th Mar 2022 GlobeNewswire
Major companies in the anti-infective drugs market include Gilead Sciences, GlaxosmithKline, Merck & Co. , Johnson & Johnson, Pfizer Inc. , AbbVie, Bayer AG, Mylan N. V. , Shionogi and F. Hoffmann-La Roche Ltd. Major companies in the anti-infective drugs market include Gilead Sciences, GlaxosmithKline, Merck & Co. , Johnson & Johnson, Pfizer Inc. , AbbVie, Bayer AG, Mylan N. V. , Shionogi and F. Hoffmann-La Roche Ltd.
Sign In
Buy JNJ